Adenocarcinoma of Colon Completed Phase 2 Trials for Floxuridine (DB00322)

Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon

Indication	Status	Phase
DBCOND0060083 (Adenocarcinoma of Colon)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00026234	Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver	Treatment	Capecitabine (DB01101) Dexamethasone (DB01234) Floxuridine (DB00322) Oxaliplatin (DB00526)